| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
84,571,000 |
| Market
Cap: |
180.14(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0.7304 - $3.24 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Esperion Therapeutics is a pharmaceutical company focused on developing and commercializing oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol (LDL-C). Co.'s first two products were approved by the U.S. Food and Drug Administration, European Medicines Agency, and Swiss Agency for Therapeutic Products. Bempedoic acid and the bempedoic acid / ezetimibe combination tablets are oral, once-daily, non-statin, LDL-C lowering medicines for patients with atherosclerotic cardiovascular disease or heterozygous familial hypercholesterolemia.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
74,217 |
| Total Buy Value |
$0 |
$0 |
$0 |
$171,738 |
| Total People Bought |
0 |
0 |
0 |
4 |
| Total Buy Transactions |
0 |
0 |
0 |
7 |
| Total Shares Sold |
192 |
192 |
1,886 |
51,771 |
| Total Sell Value |
$477 |
$477 |
$2,807 |
$239,075 |
| Total People Sold |
1 |
1 |
1 |
4 |
| Total Sell Transactions |
1 |
1 |
5 |
26 |
| End Date |
2024-02-25 |
2023-11-24 |
2023-05-26 |
2022-05-26 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Newton Roger S |
Director |
– • – |
2018-03-29 |
4 |
S |
$70.71 |
$1,146,713 |
D/D |
(15,956) |
623,726 |
|
- |
|
| Newton Roger S |
Director |
– • – |
2018-03-29 |
4 |
AS |
$73.26 |
$662,563 |
D/D |
(9,044) |
639,682 |
|
- |
|
| Janney Daniel |
Director |
– • – |
2018-02-28 |
4 |
A |
$0.00 |
$0 |
I/I |
24,565 |
24,565 |
|
- |
|
| Newton Roger S |
Director |
– • – |
2018-02-07 |
4 |
D |
$6.99 |
$25,220 |
D/D |
(3,608) |
648,726 |
|
- |
|
| Newton Roger S |
Director |
– • – |
2018-02-07 |
4 |
OE |
$6.99 |
$242,210 |
D/D |
34,651 |
652,334 |
|
- |
|
| Mayleben Timothy M |
President & CEO |
• • – |
2018-01-31 |
4 |
OE |
$1.05 |
$5,325 |
D/D |
4,549 |
46,163 |
|
- |
|
| Vitullo Nicole |
Director |
– • – |
2018-01-26 |
4 |
A |
$0.00 |
$0 |
D/D |
645 |
3,177 |
|
- |
|
| Vitullo Nicole |
Director |
– • – |
2018-01-26 |
4 |
D |
$0.00 |
$0 |
I/I |
(8,500) |
0 |
|
- |
|
| Vitullo Nicole |
Director |
– • – |
2018-01-25 |
4 |
S |
$71.79 |
$838,076 |
I/I |
(11,674) |
15,329 |
|
- |
|
| Vitullo Nicole |
Director |
– • – |
2018-01-24 |
4 |
D |
$71.82 |
$497,784 |
I/I |
(6,931) |
27,003 |
|
- |
|
| Vitullo Nicole |
Director |
– • – |
2018-01-24 |
4 |
OE |
$6.99 |
$497,933 |
I/I |
71,235 |
27,120 |
|
- |
|
| Vitullo Nicole |
Director |
– • – |
2018-01-24 |
4 |
A |
$0.00 |
$0 |
I/I |
8,500 |
8,500 |
|
- |
|
| Vitullo Nicole |
Director |
– • – |
2018-01-24 |
4 |
D |
$0.00 |
$0 |
I/I |
(850,000) |
1,037,852 |
|
- |
|
| Janney Daniel |
Director |
– • – |
2018-01-18 |
4 |
D |
$74.96 |
$497,734 |
I/I |
(6,640) |
624,564 |
|
- |
|
| Janney Daniel |
Director |
– • – |
2018-01-18 |
4 |
OE |
$6.99 |
$497,947 |
I/I |
71,237 |
631,204 |
|
- |
|
| Bartram Richard |
Chief Financial Officer |
• – – |
2018-01-02 |
4 |
OE |
$3.70 |
$66,200 |
D/D |
17,892 |
19,092 |
|
- |
|
| Janney Daniel |
Director |
– • – |
2017-12-29 |
4 |
GD |
$0.00 |
$0 |
I/I |
38,486 |
0 |
|
- |
|
| Goldstein Dov A Md |
Director |
– • – |
2017-12-18 |
4 |
D |
$0.00 |
$0 |
D/D |
(21,471) |
47 |
|
- |
|
| Goldstein Dov A Md |
Director |
– • – |
2017-12-18 |
4 |
OE |
$3.70 |
$79,443 |
D/D |
21,471 |
21,518 |
|
- |
|
| Newton Roger S |
Director |
– • – |
2017-12-12 |
4 |
GD |
$0.00 |
$0 |
D/D |
12,000 |
617,683 |
|
- |
|
| Vitullo Nicole |
Director |
– • – |
2017-12-08 |
4 |
A |
$0.00 |
$0 |
D/D |
2,472 |
2,472 |
|
- |
|
| Vitullo Nicole |
Director |
– • – |
2017-12-08 |
4 |
D |
$0.00 |
$0 |
I/I |
(32,560) |
0 |
|
- |
|
| Vitullo Nicole |
Director |
– • – |
2017-12-06 |
4 |
S |
$53.85 |
$502,205 |
I/I |
(9,326) |
25,927 |
|
- |
|
| Vitullo Nicole |
Director |
– • – |
2017-12-06 |
4 |
A |
$0.00 |
$0 |
I/I |
3,291 |
32,560 |
|
- |
|
| Vitullo Nicole |
Director |
– • – |
2017-12-06 |
4 |
D |
$0.00 |
$0 |
I/I |
(329,083) |
1,887,852 |
|
- |
|
257 Records found
|
|
Page 7 of 11 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
0.12 (5.33%) 
